Currently available COVID vaccines require cold storage and sophisticated manufacturing capacity, which makes it difficult to produce and distribute them widely, especially in less developed countries. A new type of vaccine would potentially be much easier to produce and would…
Read More
mRNA vaccine more effective booster to ChAdOx1 nCoV-19
(HealthDay)—Use of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination is more effective than homologous ChAdOx1 nCoV-19/ChAdOx1 nCoV-19 prime-boost vaccination, according to a study published online Oct. 17 in The Lancet Regional Health: Europe. Peter Nordström, M.D., Ph.D., from Umeå University…
Read More
Pediatric COVID-19 vaccine trial underway
A pediatric COVID-19 vaccine clinical trial is underway in St. Louis, led by Washington University School of Medicine. About 140 area children, ages six months to 11 years, are to receive the two-shot Moderna vaccine or placebo at St. Louis…
Read More
Hesitancy over the HPV vaccine has stabilized or risen in some subgroups
A study that tracked parental opinion about the human papillomavirus (HPV) vaccine showed that after hesitancy decreased for several years, hesitancy has now either stabilized or increased in some ethnic and age groups, according to results presented at the virtual…
Read More
AstraZeneca Invests in Imperial’s Self-Amplifying RNA Technology With Eye on Future Drugs
LONDON (Reuters) – AstraZeneca Plc on Thursday struck a deal with the firm behind Imperial College London’s experimental COVID-19 vaccine to develop and sell drugs based on its self-amplifying RNA technology platform in other disease areas. Under the deal, VaxEquity,…
Read More
Clover's vaccine 67% effective against COVID, 79% against Delta variant in large trial
BEIJING (Reuters) -A potential COVID-19 vaccine from China’s Clover Biopharmaceuticals was 67% effective against COVID-19 of any degree of severity and 79% against the highly infectious Delta variant in a large trial, the company said on Wednesday. The company has…
Read More
Multilateral system has failed badly during COVID-19 pandemic, says ISC president-elect
The multilateral system has failed badly during the COVID-19 pandemic, according to the incoming head of the International Science Council, a global body that counts the world's science academies as its members. Former New Zealand chief scientist Peter Gluckman toldSciDev.Netthat…
Read More
Study finds no serious side effects of mRNA COVID-19 vaccines in lactating women, breastfed infants
In December 2020, two novel messenger RNA (mRNA) vaccines for SARS-CoV-2 received emergency use authorization from the U.S. Food and Drug Administration; however, the early trials excluded lactating women, leading to questions about their safety in this specific population. In…
Read More
Immunological differences in Moderna and Pfizer-BioNTech vaccine-induced Fc-functional profiles
The perseverance of scientists worldwide has led to the rapid development of many SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccines and provided preventative measures against the coronavirus 2019 (COVID-19) pandemic. However, there have been many cases of breakthrough infections,…
Read More
Lack of a Vaccine Mandate Becomes Competitive Advantage in Hospital Staffing Wars
In the rural northeastern corner of Missouri, Scotland County Hospital has been so low on staff that it sometimes had to turn away patients amid a surge in covid-19 cases. The national covid staffing crunch means CEO Dr. Randy Tobler…
Read More